Latest 10-K annual reports
OQB
QDM International Inc. announced a significant increase in net income and revenue for the fiscal year ended March 31, 2025, primarily driven by a strategic reduction in referral fees and robust growth in its core insurance brokerage services in Hong Kong.
OQX
10-K: PetVivo Holdings Reports Reduced Losses Amidst Strategic Distribution Shifts and Capital Infusion
PetVivo Holdings, Inc. announced a significant reduction in its net loss for fiscal year 2025, driven by increased product sales and decreased operating expenses, while securing a substantial Series B Preferred Stock offering to bolster future operations despite ongoing going concern doubts and internal control deficiencies.
OTC.Pink
ECIA
Encision INCEncision Inc., a medical device company specializing in patient safety technology for minimally invasive surgery, reported a significant reduction in net loss and an increase in gross profit for fiscal year 2025, driven by higher service revenue and improved product margins, despite a slight decrease in overall product revenue.
NYSE
Conagra Brands reported a decrease in net sales and gross profit for fiscal year 2025, with diluted earnings per share significantly increasing due to a substantial income tax benefit and pension gain, alongside ongoing strategic divestitures and acquisitions.
NASDAQ
KalVista Pharmaceuticals, Inc. announced the landmark U.S. FDA approval of EKTERLY (sebetralstat), the first and only oral, on-demand therapy for hereditary angioedema (HAE) in patients aged 12 and older, alongside strategic global commercialization partnerships and a significant royalty financing deal.
NASDAQ
Senmiao Technology Limited reported a net loss from continuing operations of $3.47 million for the fiscal year ended March 31, 2025, alongside a strategic divestiture of its online ride-hailing platform business due to fierce competition and recurring losses.
OTC.Pink
Alixo-Yolloo Corporation filed an amendment to its annual report, adjusting prior financial statements and disclosing increased net losses, significant internal control weaknesses, and substantial doubt about its ability to continue as a going concern, despite a 75% revenue increase.
NYSE
Methode Electronics reported a net loss for fiscal year 2025, driven by declining automotive sales and increased expenses, prompting a significant amendment to its credit facility to relax financial covenants and reduce borrowing capacity.
NUKK
Nukkleus INCNukkleus Inc. filed an amendment to its annual report, revealing that its internal controls over financial reporting were not effective as of December 31, 2024, due to identified material weaknesses.
AIS Holdings Group, Inc. has ceased its IT and software development operations, becoming a blank check shell company under new leadership, facing significant financial challenges and a going concern warning.
NASDAQ
Corner Growth Acquisition Corp. 2, a blank check company, has extended its business combination deadline to December 31, 2025, following its delisting from Nasdaq and significant shareholder redemptions, while reporting a net income driven by debt forgiveness.
OQB
Avant Technologies Inc. reported a net loss of $1.14 million for fiscal year 2025, continuing its history of unprofitability and raising substantial doubt about its ability to continue as a going concern, despite strategic AI acquisitions and a planned pursuit of new financing.
OTC.Pink
ORIB
Orion Bliss CORPOrion Bliss Corp.'s latest 10-K filing reveals a significant reduction in net loss and substantial revenue growth for fiscal year 2025, despite ongoing concerns about its ability to continue as a going concern and identified material weaknesses in internal controls.
OTC.Pink
UN MONDE INTERNATIONAL LTD.'s latest 10-K filing reveals a development-stage company with no revenue, recurring losses, and significant financial liabilities, raising substantial doubt about its ability to continue as a going concern.
OID
Resonate Blends, Inc. reported a substantial increase in net loss and working capital deficit for the fiscal year ended December 31, 2024, raising significant doubt about its ability to continue as a going concern, despite a surge in revenue driven by a recent acquisition.
Adapti, Inc.'s latest annual report reveals a precarious financial state with recurring losses and negative working capital, while the company attempts to pivot through unproven AI technology and uncertain strategic acquisitions.
OQX
Butler National Corporation announced a 7% increase in total revenue to $84.0 million for fiscal year 2025, primarily fueled by a 15% surge in its Aerospace Products segment, while operating income climbed 27% to $16.8 million.
OQB
Monroe Federal Bancorp, Inc. reported a net loss of $327,000 for the fiscal year ended March 31, 2025, a significant decline from the prior year's net income, driven by decreased assets, deposit outflows, and an increase in non-performing loans following its mutual-to-stock conversion.
OQB
Hong Yuan Holding Group, a development-stage company, reported its first significant revenue of $245,572 in 2024, primarily from consolidated Chinese VIEs, but continues to face substantial net losses, an accumulated deficit of $97.8 million, and a going concern qualification from its auditors.
NASDAQ
PODC
Podcastone, INC10-K: PodcastOne Reports 20% Revenue Growth Amidst Declining Downloads and Ongoing Going Concern Doubts
PodcastOne, Inc. announced a 20% increase in revenue for fiscal year 2025, reaching $52.1 million, despite a significant 44% decrease in podcast downloads and continued substantial net losses, raising substantial doubt about its ability to continue as a going concern.
OID
Antiaging Quantum Living Inc. (AAQL) reported a dramatic increase in revenue for the fiscal year ended March 31, 2025, driven by new technical support services, but continues to face substantial net losses and a going concern warning.
AMEX
Northann Corp.'s amended annual report for fiscal year 2024 reveals a substantial accumulated deficit, a net loss, and a going concern warning from auditors, despite an increase in revenue and gross profit.
NASDAQ
National Beverage Corp. reported a 0.8% increase in net sales to $1.2014 billion and a 5.7% rise in net income to $186.8 million for Fiscal 2025, driven by higher selling prices and reduced costs despite a slight decrease in case volume.
NASDAQ
Kewaunee Scientific Corporation reported increased sales driven by its Nu Aire acquisition but experienced a decline in net earnings for fiscal year 2025, while maintaining a strong order backlog.
NASDAQ
Aeries Technology Inc. reported a substantial net loss of $21.6 million for fiscal year 2025, alongside a working capital deficit and a significant customer contract non-renewal, raising substantial doubt about its ability to continue as a going concern.
NASDAQ
Credo Technology Group Holding Ltd reported a significant financial turnaround in fiscal year 2025, achieving net income of $52.2 million on record revenue of $436.8 million, primarily fueled by surging demand for its high-speed connectivity solutions in AI and hyperscale data centers.
NASDAQ
Midland States Bancorp, Inc. has restated prior financial statements due to accounting errors in third-party loan programs, reported a substantial decline in 2024 net income, and anticipates a significant goodwill impairment charge in Q1 2025, reflecting deteriorating credit quality and strategic portfolio reductions.
OID
SUIC Worldwide Holdings Ltd. reported a net loss of $234,211 for fiscal year 2024, narrowing losses from the prior year, while continuing to develop its fintech and supply chain integration ventures.
AMEX
Northann Corp. reported a 10% increase in revenue and a significant improvement in gross profit for fiscal year 2024, driven by strategic acquisitions and a planned shift to U.S. manufacturing, despite a continued net loss and an auditor's going concern opinion.
OTC.Pink
10-K/A: IMAC Holdings Pivots to Oncology Proteomics Amidst Financial Restatement and Nasdaq Delisting
IMAC Holdings, Inc. has undergone a significant strategic shift, divesting its previous patient care operations to focus entirely on oncology proteomics, while simultaneously addressing a financial restatement and navigating a delisting from Nasdaq.